0001493152-18-014262.txt : 20181009 0001493152-18-014262.hdr.sgml : 20181009 20181009161347 ACCESSION NUMBER: 0001493152-18-014262 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20181009 DATE AS OF CHANGE: 20181009 EFFECTIVENESS DATE: 20181009 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OncBioMune Pharmaceuticals, Inc CENTRAL INDEX KEY: 0001362703 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 202590810 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-323113 FILM NUMBER: 181113804 BUSINESS ADDRESS: STREET 1: 11441 INDUSTRIPLEX BLVD STREET 2: SUITE 190 CITY: BATON ROUGE STATE: LA ZIP: 70809 BUSINESS PHONE: 225-227-2384 MAIL ADDRESS: STREET 1: 11441 INDUSTRIPLEX BLVD STREET 2: SUITE 190 CITY: BATON ROUGE STATE: LA ZIP: 70809 FORMER COMPANY: FORMER CONFORMED NAME: QUINT MEDIA INC. DATE OF NAME CHANGE: 20130807 FORMER COMPANY: FORMER CONFORMED NAME: PediatRx Inc. DATE OF NAME CHANGE: 20101230 FORMER COMPANY: FORMER CONFORMED NAME: Striker Energy Corp DATE OF NAME CHANGE: 20060515 D 1 primary_doc.xml X0708 D LIVE 0001362703 OncBioMune Pharmaceuticals, Inc 11441 INDUSTRIPLEX BLVD., SUITE 190 BATON ROUGE LA LOUISIANA 70809 225 227-2384 NEVADA Striker Energy Corp. QUINT MEDIA INC. PediatRx Inc. Striker Energy Corp Corporation true Jonathan F. Head 11441 Industriplex Blvd Baton Rouge LA LOUISIANA 70809 Executive Officer Director Andrew Kucharchuk 11441 Industriplex Blvd., Suite 190 Baton Rouge LA LOUISIANA 70809 Executive Officer Daniel S. Hoverman 11441 Industriplex Blvd., Suite 190 Baton Rouge LA LOUISIANA 70809 Director Issuer expects to use proceeds from the offering for working capital purposes which includes payment of salaries to the named persons. Charles L. Rice, Jr. 11441 Industriplex Blvd., Suite 190 Baton Rouge LA LOUISIANA 70809 Director Robert N. Holcomb 11441 Industriplex Blvd., Suite 190 Baton Rouge LA LOUISIANA 70809 Director Biotechnology Decline to Disclose 06b false 2018-09-24 false true true false 0 1225000 1225000 0 false 4 0 0 0 Issuer expects to use proceeds from the offering for working capital purposes which includespayment of salaries to the named persons. false OncBioMune Pharmaceuticals, Inc /s/ Jonathan F. Head Jonathan F. Head Chief Executive Officer 2018-10-09